Entering Life Sciences Market, Appistry Reworks Cloud Offering for NGS Data Analysis | GenomeWeb

By Uduak Grace Thomas

Cloud computing firm Appistry this week threw its hat in the bioinformatics ring with a version of its CloudIQ platform that provides a complete data-analysis pipeline for next-generation sequencing data.

Dubbed Ayrris/Bio, the new product marks the first offering from a dedicated life-sciences group that the company put in place earlier this year to develop and commercialize technologies for genomic data analysis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.